Home › Products › Oncology › Womab Injection
Womab Injection
Salt Composition: PERTUZUMAB
- Manufacturer: DR REDDY'S LABORATORIES LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 420MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Keep Womab Injection out of sight and reach of children. Store in refrigerator at 2°C to 8°C. Do not freeze.
₹59995.00₹74992.50
Inclusive of all taxes
Product Introduction
Womab Injection is an anticancer medication containing the active constituent Pertuzumab. It is used to treat HER2-positive breast cancer in combination with other chemotherapy medications. Cancer is a condition in which cells multiply uncontrolled and abnormally. Womab Injection is not recommended for adolescents and children under 18 years of age. Before taking this medicine, it is vital to inform your doctor if you have or have ever had heart problems or previous chemotherapy. Use effective birth control during treatment and for at least six months after the last dose. Inform your doctor if you have kidney disease before starting with this Pertuzumab injection. Patients with kidney disease should use this medicine with caution. Ensure you inform your physician of all medicines, including supplements and herbal medicines, you are taking before you start treatment with this medicine. Do not stop taking this medication without talking to your physician first.
Uses
HER2-positive breast cancer
How it works
Womab Injection binds to the human epidermal growth factor receptor 2 (HER2) on cancer cells, potentially destroying or inhibiting cancer cell growth.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious Severe or persistent diarrhea Low white blood cell count Infusion reactions (fever, chills, hot flushes, nausea, headache, joint, and muscle pain) Severe allergic reactions (swelling of throat and face, difficulty in breathing) Heart problems (cough, swelling in arms or legs, shortness of breath) Tumour lysis syndrome (confusion, tiredness, irregular heartbeat, seizures, tingling sensation) Common Hair loss Rash Sore mouth Constipation Poor appetite Changes in taste Sleeping troubles Nose bleeds Heartburn Nail problems Producing more tears Feeling dizzy Dry and itchy skin Ear, nose, or throat infection.
References
- Roche Products Ltd, Electronic medicines compendium (emc), [Revised on January 2022] [ Accessed on 15 March 2023], https://www.medicines.org.uk/emc/files/pil.2993.pdf
- Komal Jhaveri, Francisco J Esteva; Pertuzumab in the treatment of HER2+ breast cancer; Journal of the National Comprehensive Cancer Network; Published on April 2014; Accessed on 15 March 2023; https://pubmed.ncbi.nlm.nih.gov/24717573/
- Kei Ishii; Pertuzumab in the treatment of HER2-positive breast cancer: An evidence-based review of its safety, efficacy, and place in therapy; [Published online on 31st Oct 2019];[Accessed on 21st Feb 2023]; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827570
Safety Advice
Pregnancy: Consult Your Doctor Inform your doctor in case you are pregnant, think you might be pregnant or are planning to get pregnant, as Womab Injection may be unsafe during pregnancy.
Lungs: Consult Your Doctor It is unknown whether Womab Injection is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Breastfeeding: Unsafe It may be unsafe to take Womab Injection while breastfeeding. Consult your doctor if you are breastfeeding before taking this medication.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.